261 related articles for article (PubMed ID: 30465510)
1. Current Breakthroughs in Structure-based Design of Synthetic and Natural Sourced Inhibitors Against Zika Viral Targets.
Nandi S; Kaur R; Kumar M; Sharma A; Naaz A; Mandal SC
Curr Top Med Chem; 2018; 18(20):1792-1803. PubMed ID: 30465510
[TBL] [Abstract][Full Text] [Related]
2. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening.
Singh A; Jana NK
Comput Biol Chem; 2017 Dec; 71():144-151. PubMed ID: 29096380
[TBL] [Abstract][Full Text] [Related]
4. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
5. Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.
Saiz JC; Oya NJ; Blázquez AB; Escribano-Romero E; Martín-Acebes MA
Viruses; 2018 Aug; 10(9):. PubMed ID: 30149598
[TBL] [Abstract][Full Text] [Related]
6. Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials.
Elfiky AA
J Med Virol; 2016 Dec; 88(12):2044-2051. PubMed ID: 27604059
[TBL] [Abstract][Full Text] [Related]
7. The A-Z of Zika drug discovery.
Mottin M; Borba JVVB; Braga RC; Torres PHM; Martini MC; Proenca-Modena JL; Judice CC; Costa FTM; Ekins S; Perryman AL; Horta Andrade C
Drug Discov Today; 2018 Nov; 23(11):1833-1847. PubMed ID: 29935345
[TBL] [Abstract][Full Text] [Related]
8. Natural products as Zika antivirals.
Fong YD; Chu JJH
Med Res Rev; 2022 Sep; 42(5):1739-1780. PubMed ID: 35593443
[TBL] [Abstract][Full Text] [Related]
9. Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery.
Ramharack P; Soliman MES
J Biomol Struct Dyn; 2018 Apr; 36(5):1118-1133. PubMed ID: 28351337
[TBL] [Abstract][Full Text] [Related]
10. Identification of Ascomycin against Zika virus infection through screening of natural product library.
Zhou L; Zhou J; Chen T; Chi X; Liu X; Pan S; Chen W; Wu T; Lin T; Zhang X; Li YP; Yang W
Antiviral Res; 2021 Dec; 196():105210. PubMed ID: 34801589
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
13. RNA-dependent RNA polymerase: Addressing Zika outbreak by a phylogeny-based drug target study.
Stephen P; Lin SX
Chem Biol Drug Des; 2018 Jan; 91(1):322-327. PubMed ID: 28636772
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors.
Gao Y; Tai W; Wang N; Li X; Jiang S; Debnath AK; Du L; Chen S
Viruses; 2019 Nov; 11(11):. PubMed ID: 31684080
[TBL] [Abstract][Full Text] [Related]
15. Repurposing drugs for use against Zika virus infection.
Devillers J
SAR QSAR Environ Res; 2018 Feb; 29(2):103-115. PubMed ID: 29299939
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel small-molecule inhibitors of Zika virus infection.
Micewicz ED; Khachatoorian R; French SW; Ruchala P
Bioorg Med Chem Lett; 2018 Feb; 28(3):452-458. PubMed ID: 29258771
[TBL] [Abstract][Full Text] [Related]
17. Strategies for Zika drug discovery.
Zou J; Shi PY
Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
[TBL] [Abstract][Full Text] [Related]
19. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.
Han Y; Mesplède T
Expert Opin Investig Drugs; 2018 Dec; 27(12):951-962. PubMed ID: 30430882
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targets and biological mechanisms of action of curcumin against Zika virus: In silico and in vitro analyses.
Kim M; Choi H; Kim YB
Eur J Pharmacol; 2021 Aug; 904():174144. PubMed ID: 33957087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
